Orap Related Published Studies
Well-designed clinical trials related to Orap (Pimozide)
Efficacy of pimozide augmentation for clozapine partial responders with
schizophrenia. [2013]
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy. [2011.05]
Quantitative determination of pimozide in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study. [2010.04.06]
Pimozide for tics in Tourette's syndrome. [2009.04.15]
Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. [2005.02]
Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. [2004.02]
Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. [2001.01]
Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. [2000.06]
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). [1999.01]
[Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis. Introductory notes] [1998.07]
Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. [1997.08]
Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome. [1996.11.15]
Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. [1996.01.01]
Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder. [1994.07]
Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. [1990.11]
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. [1989.08]
Well-designed clinical trials possibly related to Orap (Pimozide)
Non-antiepileptic drugs for trigeminal neuralgia. [2013]
The role of nutrition in the regulation of luteinizing hormone secretion by the opioidergic, dopaminergic, and serotonergic systems in female Mediterranean goats. [2011.03]
Non-antiepileptic drugs for trigeminal neuralgia. [2011.01.19]
Non-antiepileptic drugs for trigeminal neuralgia. [2011]
Delusional infestation in dermatology in the UK: prevalence, treatment strategies, and feasibility of a randomized controlled trial. [2010.12]
Delusional infestation in dermatology in the UK: prevalence, treatment strategies, and feasibility of a randomized controlled trial. [2010.02.22]
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. [2010.01]
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. [2007.03]
Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. [2006.09]
Non-antiepileptic drugs for trigeminal neuralgia. [2006.07.19]
Does a four-week delay in the introduction of medication alter the course of functional psychosis? [1999]
Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. [1993]
The role of dopaminergic and noradrenergic receptors in human TSH and LH release. [1989.04]
The Northwick Park "functional" psychosis study: diagnosis and treatment response. [1988.07.16]
Dextro-amphetamine diminishes negative symptoms in schizophrenia. [1988.04]
Other research related to Orap (Pimozide)
Pimozide for schizophrenia or related psychoses. [2013]
Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats. [2011.08]
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. [2011.03.24]
Quantitative determination of pimozide in human plasma by liquid
chromatography-mass spectrometry and its application in a bioequivalence study. [2010]
Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. [2009.09.29]
A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection. [2009.02]
Pimozide for schizophrenia or related psychoses. [2007.07.18]
Fetal exposure to pimozide: a case report. [2006.05]
Bait-delivered pimozide causes precocious embryo implantation in mink: a fertility control option for the exotic stoat? [2006]
Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers. [2005.07]
Delayed dystonia following pimozide overdose in a child. [2004]
Pimozide in dermatologic practice: a comprehensive review. [2004]
Pimozide injections into the Nucleus accumbens disrupt maternal behaviour in lactating rats. [2003.07]
Pimozide: use in dermatology. [2003.03]
Cavernous hemangioma in a child presenting with hemichorea: response to pimozide. [2001.09]
Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. [2000.06]
Pimozide for schizophrenia or related psychoses. [2000]
Effects of long-term testosterone, gonadotropin-releasing hormone agonist, and pimozide treatments on gonadotropin II levels and ovarian development in juvenile female striped bass (Morone saxatilis). [1998.11]
Effects of pimozide on the psychopathology of delusional disorder. [1998.02]
Pimozide-induced depression in men who stutter. [1997.10]
High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. [1997.02]
The successful treatment of a gender dysphoric patient with pimozide. [1996.06]
Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels. [1995.12.29]
Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication. [1995.06]
Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. [1994.05]
Differential sensitivity of operant behaviors to changes in the concentration of a sucrose reinforcer: effects of pimozide. [1994.03]
Differential tolerance to the behavioral effects of chronic pimozide and clozapine on multiple random interval responding in rats. [1993.06]
Acute dystonic reaction with low-dose pimozide. [1993.05]
Improvement of trigeminal neurotrophic ulceration with pimozide in a cognitively impaired elderly woman--a case report. [1993.03]
Clinical uses of pimozide. [1993.03]
Possible interaction between fluoxetine and pimozide causing sinus bradycardia. [1993.02]
Successful treatment of litigious paranoia with pimozide. [1993.02]
[Pimozide in the treatment of psychogenic eating disorders] [1993.01]
Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. [1993.01]
Successful treatment with pimozide of Capgras syndrome in an elderly male. [1992.10]
Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. [1992.04]
Influence of pimozide on a TRH induced TSH secretion in the rat during food deprivation. [1992.02]
Pimozide in autistic children. [1992]
[Three cases of hyponatremia during administration of pimozide] [1991.09]
The role of pimozide in clinical psychiatry: a review. [1991.05]
Time-, schedule-, and reinforcer-dependent effects of pimozide and amphetamine. [1991]
Three thousand days of pregnancy. A case of monosymptomatic delusional pseudocyesis responding to pimozide. [1990.12]
Dissociation of the attentional and motivational effects of pimozide on the threshold for rewarding brain stimulation. [1990.02]
Pimozide therapy for trigeminal neuralgia. [1989.09]
Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine. [1989.08]
Pimozide in pathological jealousy. [1989.08]
Assessment of pimozide's motor and hedonic effects on operant behavior in rats. [1988.12]
Pimozide treatment of the negative schizophrenic syndrome: an open trial. [1988.06]
Definite and sustained improvement with pimozide of two patients with severe trigeminal neuralgia. Some neurochemical, neurophysiological and neuroendocrinological findings. [1988]
Effects of pimozide, across doses and within sessions, on discriminated lever release performance in rats. [1988]
Pharmacokinetics of pimozide in adults and children with Tourette's syndrome. [1987.10]
Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent? [1987]
Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide. [1979]
Other possibly related research studies
Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter. [2005]
Antipsychotic poisoning in young children: a systematic review. [2005]
Erotomania : epidemiology and management. [2005]
Effects of medications on regulation of body temperature of patients with Tourette syndrome. [2004.03]
Delusional parasitosis: case series of 8 patients and review of the literature. [2004.01]
Drug interactions of clinical significance for the dermatologist: recognition and avoidance. [2003]
[A child with peculiar movements: Sydenham chorea] [2003.02.08]
P300 changes in major depressive disorders with and without psychotic features. [2003.02]
[Delusions of parasitosis: An up-to-date review] [2002.10]
Trigeminal neuralgia: current concepts and management. [2001.12]
Gilles de la Tourette syndrome in a child with congenital deafness. [2001.12]
Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. [2001]
Effects of dopaminergic and cholinergic interactions on rat behavior. [2001.10.05]
Ophthalmic manifestations of gilles de la Tourette syndrome. [2001.07]
Plasma steroids in mature common dentex (Dentex dentex) stimulated with a gonadotropin-releasing hormone agonist. [2001.07]
Gilles de la Tourette syndrome: symptomatic treatment based on evidence. [2000]
Personality disorders and traits in patients with body dysmorphic disorder. [2000.07]
|
